The SEQDESIGN Procedure
-
Overview
- Getting Started
-
Syntax
-
DetailsFixed-Sample Clinical TrialsOne-Sided Fixed-Sample Tests in Clinical TrialsTwo-Sided Fixed-Sample Tests in Clinical TrialsGroup Sequential MethodsStatistical Assumptions for Group Sequential DesignsBoundary ScalesBoundary VariablesType I and Type II ErrorsUnified Family MethodsHaybittle-Peto MethodWhitehead MethodsError Spending MethodsAcceptance (beta) BoundaryBoundary Adjustments for Overlapping Lower and Upper beta BoundariesSpecified and Derived ParametersApplicable Boundary KeysSample Size ComputationApplicable One-Sample Tests and Sample Size ComputationApplicable Two-Sample Tests and Sample Size ComputationApplicable Regression Parameter Tests and Sample Size ComputationAspects of Group Sequential DesignsSummary of Methods in Group Sequential DesignsTable OutputODS Table NamesGraphics OutputODS Graphics
-
ExamplesCreating Fixed-Sample DesignsCreating a One-Sided O’Brien-Fleming DesignCreating Two-Sided Pocock and O’Brien-Fleming DesignsGenerating Graphics Display for Sequential DesignsCreating Designs Using Haybittle-Peto MethodsCreating Designs with Various Stopping CriteriaCreating Whitehead’s Triangular DesignsCreating a One-Sided Error Spending DesignCreating Designs with Various Number of StagesCreating Two-Sided Error Spending Designs with and without Overlapping Lower and Upper beta BoundariesCreating a Two-Sided Asymmetric Error Spending Design with Early Stopping to Reject H0Creating a Two-Sided Asymmetric Error Spending Design with Early Stopping to Reject or Accept H0Creating a Design with a Nonbinding Beta BoundaryComputing Sample Size for Survival Data That Have Uniform AccrualComputing Sample Size for Survival Data with Truncated Exponential Accrual
- References
In addition to computing the boundary values for a group sequential design, the SEQDESIGN procedure computes the following quantities:
-
maximum sample size (as a percentage of the corresponding fixed-sample size) if the trial does not stop at an interim stage
-
average sample numbers (as percentages of the corresponding fixed-sample sizes for nonsurvival data or fixed-sample numbers of events for survival data) under various hypothetical references, including the null and alternative references
-
stopping probabilities at each stage under various hypothetical references to indicate how likely it is that the trial will stop at that stage
-
sample sizes required at each stage for the specified hypothesis test
-
numbers of events required at each stage for the specified hypothesis test with survival data
You can create more than one design with multiple DESIGN statements in the SEQDESIGN procedure and then choose the design with the most desirable features. The next two subsections introduce some basic aspects of group sequential designs that are useful for getting started with the SEQDESIGN procedure.